Morgan Stanley upgraded Keurig Dr Pepper (KDP) to Overweight from Equal Weight with a price target of $40, up from $38. The firm, which thinks the market is not recognizing the company’s building organic sales and EPS growth prospects compared to consumer packaged goods peers, cites highly visible strength in its U.S. refreshment segment and continued solid international results despite short-term coffee profit risk. The firm, which sees U.S. refreshment being boosted by sustained strong category pricing power, as well as consistent market share gains, sees durability in these growth drivers, the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Keurig Dr Pepper Secures New $4 Billion Credit Agreement
- Trump Trade: Trump ‘couldn’t care less’ if carmakers raise prices
- RFK Jr. says states can block use of SNAP benefits on soft drinks, NY Times says
- Citi Cheers Samuel Adams Parent Boston Beer Stock (NYSE:SAM) Ahead of Sun Cruiser Launch
- Citi names Keurig Dr Pepper top pick in beverages, personal care
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue